Arphra/Issuer/NRXP

NRXP

NRx Pharmaceuticals, Inc.

HealthcareBiotechnologyUSUSD

$4.42

LiveMay 29, 2026

AI Brief

Market cap

$76.4M

52w range

1.62 – 4.58

P / E

—

EPS

—

Volume

1.25M

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on NRx Pharmaceuticals, Inc.’s valuation

Multiples · NRXP

Historical valuation

TTM/LTM-basis multiples with σ-banded history. Fair value below uses current denominator and FY2027 consensus.

1 year 3 years 5 years

The key_metrics_ttm loader hasn't indexed enough history for NRXP to build a Z-scored multiples view yet. Try a shorter period or check back after the next daily run.

P/E (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

EV / EBITDA (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

EV / Sales (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

Dividend yield (TTM)

Not enough history to compute a Z-score for this multiple (3y · n=0).

No peer set loaded for NRXP. Run the peers loader to populate the comparison.

Pro

Multiples

Valuation multiples and peer comparisons are included with Pro.

Upgrade to Pro